Detection of Treponema pallidum in whole blood samples of patients with syphilis by the polymerase chain reaction.


Journal

Revista do Instituto de Medicina Tropical de Sao Paulo
ISSN: 1678-9946
Titre abrégé: Rev Inst Med Trop Sao Paulo
Pays: Brazil
ID NLM: 7507484

Informations de publication

Date de publication:
2022
Historique:
received: 31 03 2022
accepted: 16 08 2022
entrez: 16 11 2022
pubmed: 17 11 2022
medline: 19 11 2022
Statut: epublish

Résumé

Syphilis is caused by the bacterium Treponema pallidum. The diagnosis is based on clinical data and serological analysis; however, the sensitivity and specificity of such tests may vary depending on the type of test and stage of the infection. In order to overcome this premise, this study utilized the polymerase chain reaction (PCR) for the detection of T. pallidum DNA in whole blood samples of patients with syphilis. The blood samples from patients with or without symptoms of syphilis, but with positive results in enzyme-linked immunosorbent assay (ELISA), were included in this study. A venereal disease research laboratory (VDRL) test was performed for all collected sera samples. For PCR, the T. pallidum DNA was extracted from the collected blood samples and a specific primer set was designed to amplify 131 nucleotides of polA (Tp0105). The specificity of the primers was evaluated with the DNA of 17 different pathogens. From a total of 314 blood samples reactive in ELISA, 58.2% (183/314) of the samples were reactive in the VDRL test. In the PCR, 54% (168/314) of the ELISA-reactive samples were positive. In both tests (VDRL and PCR) 104 samples were positive. Of 104 positive samples for both tests, 71 were at the latent stage. Based on these results, it can be concluded that PCR with the designed set of primers can be utilized as a diagnostic method for T. pallidum detection in blood samples of patients with syphilis, especially those with latent infection. In addition, it can be utilized as a supplement for serological methods to improve the diagnosis of syphilis.

Identifiants

pubmed: 36383897
pii: S0036-46652022000100242
doi: 10.1590/S1678-9946202264075
pmc: PMC9673146
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e75

Références

Bull World Health Organ. 2019 Aug 01;97(8):548-562P
pubmed: 31384073
Clin Infect Dis. 2020 Jun 24;71(Suppl 1):S43-S51
pubmed: 32578864
Sex Transm Infect. 2009 Aug;85(4):264-9
pubmed: 19155240
Microb Pathog. 2017 Mar;104:296-302
pubmed: 28161356
J Dig Dis. 2018 May;19(5):272-278
pubmed: 29722130
Diagn Microbiol Infect Dis. 2001 Aug;40(4):163-6
pubmed: 11576788
Clin Vaccine Immunol. 2015 Feb;22(2):137-47
pubmed: 25428245
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187
pubmed: 34292926
J Clin Microbiol. 2006 Sep;44(9):3452-6
pubmed: 16954299
Rev Inst Med Trop Sao Paulo. 2021 Jan 29;63:e4
pubmed: 33533807
Clin Infect Dis. 2020 Jun 24;71(Suppl 1):S4-S12
pubmed: 32578865
Sex Transm Dis. 2019 Jan;46(1):41-46
pubmed: 30247262
J Clin Pathol. 2008 Mar;61(3):390-5
pubmed: 17557863
Curr Opin Infect Dis. 2015 Feb;28(1):53-60
pubmed: 25485649
J Clin Microbiol. 2001 May;39(5):1941-6
pubmed: 11326018
Ocul Immunol Inflamm. 2013 Jun;21(3):227-30
pubmed: 23617827
J Clin Microbiol. 2021 Sep 20;59(10):e0010021
pubmed: 33980644
Front Cell Infect Microbiol. 2021 Feb 08;10:574806
pubmed: 33628742
Emerg Microbes Infect. 2018 May 9;7(1):83
pubmed: 29739928
J Eur Acad Dermatol Venereol. 2021 Mar;35(3):574-588
pubmed: 33094521
J Clin Microbiol. 2012 Mar;50(3):546-52
pubmed: 22219306
BMC Bioinformatics. 2012 Jun 18;13:134
pubmed: 22708584
PLoS One. 2020 Aug 20;15(8):e0237949
pubmed: 32817658
Epidemiol Serv Saude. 2021 Mar 15;30(spe1):e2020616
pubmed: 33729409
Sex Transm Infect. 2013 May;89(3):251-6
pubmed: 23024223
Am J Trop Med Hyg. 2017 Oct;97(4):1078-1084
pubmed: 28820706
Diagn Microbiol Infect Dis. 2016 Feb;84(2):105-11
pubmed: 26607421
Emerg Infect Dis. 2015 Jan;21(1):127-9
pubmed: 25531672
Nat Rev Dis Primers. 2017 Oct 12;3:17073
pubmed: 29022569
Clin Infect Dis. 2020 Jun 24;71(Suppl 1):S21-S42
pubmed: 32578862
Int J STD AIDS. 2007 Dec;18(12):842-5
pubmed: 18073019

Auteurs

Júlio Henrique Ferreira de Sá Queiroz (JHFS)

Universidade Federal da Grande Dourados, Laboratório de Pesquisa em Ciências da Saúde, Dourados, Mato Grosso do Sul, Brazil.

Maisa Estopa Correa (ME)

Universidade Federal da Grande Dourados, Laboratório de Pesquisa em Ciências da Saúde, Dourados, Mato Grosso do Sul, Brazil.

Tiago da Silva Ferreira (TDS)

Universidade Federal da Grande Dourados, Laboratório de Pesquisa em Ciências da Saúde, Dourados, Mato Grosso do Sul, Brazil.

Michele Ferreira Marques (MF)

Universidade Federal da Grande Dourados, Laboratório de Pesquisa em Ciências da Saúde, Dourados, Mato Grosso do Sul, Brazil.

Marcelo Dos Santos Barbosa (MDS)

Universidade Federal da Grande Dourados, Laboratório de Pesquisa em Ciências da Saúde, Dourados, Mato Grosso do Sul, Brazil.

Silvana Beutinger Marchioro (SB)

Universidade Federal da Bahia, Instituto de Ciências da Saúde, Laboratório de Imunologia e Biologia Molecular, Salvador, Bahia, Brazil.

Simone Simionatto (S)

Universidade Federal da Grande Dourados, Laboratório de Pesquisa em Ciências da Saúde, Dourados, Mato Grosso do Sul, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH